Jeffrey Stokes

Medicine & Life Sciences

1. Asthma 100%
2. Allergic Rhinitis 48%
3. Immunotherapy 48%
4. Omalizumab 43%
5. Immunologic Desensitization 41%
6. Immunologic Factors 30%
7. Immunoglobulin E 27%
8. Allergens 25%
9. Therapeutics 24%
10. Hypersensitivity 19%
11. anti-IgE antibodies 19%
12. Inflammation 18%
13. N-ethyl-3-fluoro-3-(3-fluoro-4-(pyrrolidinylmethyl)phenyl)cyclobutanecarboxamide 18%
14. Skin Tests 15%
15. Histamine Antagonists 14%
16. Ambrosia 13%
17. Clinical Trials 13%
18. Toll-Like Receptors 13%
19. mepolizumab 12%
20. fexofenadine 11%
21. Histamine H3 Receptors 11%
22. Adrenal Cortex Hormones 11%
23. Safety 10%
24. Nose 10%
25. Leukotrienes 10%
26. Venoms 10%
27. Respiratory Sounds 10%
28. Airway Obstruction 10%
29. Imiquimod 10%
30. Phenotype 10%
31. Allergoids 10%
32. Child 10%
33. Immunomodulation 8%
34. Pediatrics 8%
35. Preschool Children 8%
36. Placebos 8%
37. Cytokines 8%
38. Primary Care Physicians 8%
39. Cannabis 8%
40. Non-Sedating Histamine H1 Antagonists 8%
41. Eosinophils 7%
42. Respiratory System 6%
43. Quality of Life 6%
44. Leukocyte Count 5%
45. Viruses 5%
46. Subcutaneous Injections 5%
47. Peroxisome Proliferator-Activated Receptors 5%
48. Syk Kinase 5%